Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy

• Status: Completed
• Trial end date: 2015-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the efficacy and safety of topic ketorolac in treatment for center point thickness secondary to panphotocoagulation in proliferative diabetic retinopathy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital Juarez de Mexico
• Treatments: Ethanol; Ketorolac; Ketorolac Tromethamine

Criteria

Inclusion Criteria:

• type 2 diabetes

• proliferative diabetic retinopathy

• without macular edema

• adequate quality 6 mm fast macular map on the day of treatment

• visual capacity under subjective refraction before treatment

• signed of inform consent

Exclusion Criteria:

• ocular surgery in the last 4 months

• myopia over -6.00 diopters

• allergy to ketorolac or non-steroids antiinflammatory

• previous selective photocoagulation

• using non-steroids antiinflammatory or immunomodulators

• intraocular inflammatory

• any retinal disease different from diabetic retinopathy

• pregnancy

• actual corneal disease

• inadequate quality 6 mm fast macular map after the second visit

• inconsistency after the second visit

• adverse event of the drug

• remove of the inform consent